NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Pentoxifylline

Last Revision: July 20, 2020.

Estimated reading time: 1 minute

CASRN: 6493-05-6

image 134986479 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Limited data indicate that pentoxifylline is poorly excreted into breastmilk. It would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.

Drug Levels

Maternal Levels. Five women who had been breastfeeding for at least 6 weeks received a single 400 mg oral dose of a sustained-release form of pentoxifylline. The average total milk concentration of pentoxifylline plus its 3 active metabolites was 419 mcg/L at 2 hours after the dose and 982 mcg/L at 4 hours.[1] Using the peak milk level data from this study, an exclusively breastfed infant would receive an estimated maximum of 147 mcg/kg daily with this maternal dosage regimen or about 2% of the maternal weight-adjusted dosage.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Witter FR, Smith RV. The excretion of pentoxifylline and its metabolites into human breast milk. Am J Obstet Gynecol. 1985;151:1094–7. [PubMed: 3985069]

Substance Identification

Substance Name

Pentoxifylline

CAS Registry Number

6493-05-6

Drug Class

Breast Feeding

Lactation

Hematologic Agents

Phosphodiesterase Inhibitors

Platelet Aggregation Inhibitors

Xanthines

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Dyphylline[Drugs and Lactation Database (...]
    Review Dyphylline
    . Drugs and Lactation Database (LactMed). 2006
  • Review Clobazam[Drugs and Lactation Database (...]
    Review Clobazam
    . Drugs and Lactation Database (LactMed). 2006
  • Review Nifedipine[Drugs and Lactation Database (...]
    Review Nifedipine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Droperidol[Drugs and Lactation Database (...]
    Review Droperidol
    . Drugs and Lactation Database (LactMed). 2006
  • Review Nitrazepam[Drugs and Lactation Database (...]
    Review Nitrazepam
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...